Komori
General Meetings of Shareholders197ATAUNS Laboratories,Inc.Pharmaceuticals

Notice of Convocation of the 11th Annual General Meeting of Shareholders

At the 11th Annual General Meeting of Shareholders, proposals will be submitted concerning the disposition of surplus, partial amendments to the Articles of Incorporation, the election of directors, and the determination of directors’ remuneration. The Articles of Incorporation will be amended to transition to a company with an Audit and Supervisory Committee.

Worth reading
59In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (11th fiscal year)
2026
Sep 25
Date and time(Friday), 10:00 a.m. (registration scheduled to open at 9:30 a.m.)23 days from this disclosure to the meeting
Matters for resolution6 items
  1. Appropriation of surplus

  2. Partial amendments to the Articles of Incorporation

  3. Election of 2 directors (excluding directors serving as Audit and Supervisory Committee Members)

  4. Election of 3 Directors serving as Audit and Supervisory Committee Members

  5. Proposal for the determination of the amount of compensation, etc. for directors, excluding directors serving as Audit and Supervisory Committee members

  6. Proposal for the determination of the amount of compensation, etc. for directors serving as Audit and Supervisory Committee members

Shareholder Proposal

None (not specified)

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nominee
5Nominees
3New
3Outside
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (11th fiscal year)
Date and time25 September 2026 (Friday), 10:00 a.m. (registration scheduled to open at 9:30 a.m.)
Matters for resolutionAppropriation of surplus, Partial amendments to the Articles of Incorporation, Election of 2 directors (excluding directors serving as Audit and Supervisory Committee Members), Election of 3 Directors serving as Audit and Supervisory Committee Members, Proposal for the determination of the amount of compensation, etc. for directors, excluding directors serving as Audit and Supervisory Committee members, Proposal for the determination of the amount of compensation, etc. for directors serving as Audit and Supervisory Committee members
Shareholder ProposalNone (not specified)
Director nominee5 candidates, including 3 new candidates and 3 outside directors
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company will transition to a company with an Audit and Supervisory Committee to add business purposes in response to business diversification, strengthen audit and supervisory functions, and accelerate decision-making.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Convocation of the 11th Annual General Meeting of Shareholders | TAUNS Laboratories,Inc. (197A) timely disclosure | Komori